Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy

Albarakati, N., Abdel-Fatah, T.M.A., Doherty, R. orcid.org/0000-0002-3979-961X et al. (14 more authors) (2014) Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology , 9 (1). pp. 204-217. ISSN 1574-7891

Abstract

Metadata

Authors/Creators:
  • Albarakati, N.
  • Abdel-Fatah, T.M.A.
  • Doherty, R. https://orcid.org/0000-0002-3979-961X
  • Russell, R.
  • Agarwal, D.
  • Moseley, P.
  • Perry, C.
  • Arora, A.
  • Alsubhi, N.
  • Seedhouse, C.
  • Rakha, E.A.
  • Green, A.
  • Ball, G.
  • Chan, S.
  • Caldas, C.
  • Ellis, I.O.
  • Madhusudan, S.
Copyright, Publisher and Additional Information: © 2014 Wiley
Keywords: BRCA1; Base excision repair; ATM; DNA-PK; Small molecule inhibitors; Synthetic lethality; Cisplatin; Chemopotentiation
Dates:
  • Published (online): 27 August 2014
Institution: The University of Sheffield
Depositing User: Symplectic Sheffield
Date Deposited: 10 Aug 2018 11:29
Last Modified: 10 Aug 2018 11:29
Published Version: https://doi.org/10.1016/j.molonc.2014.08.001
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.molonc.2014.08.001
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics